Extracellular Vesicles from Mesenchymal Stem Cells
KY2022-205
Phase 1 mab active
Quick answer
Extracellular Vesicles from Mesenchymal Stem Cells for COVID-19 Pneumonia is a Phase 1 program (mab) at Regen BioPharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regen BioPharma Inc
- Indication
- COVID-19 Pneumonia
- Phase
- Phase 1
- Modality
- mab
- Status
- active